pre-update Archives

Business transparency, integrity or data disclosure concept, businessman standing with disclosure financial document in crystal clear fish bowl

Blog

EU-CTR Challenges Drug Developers Faced in the First 6 Months

Under European Union Clinical Trial Regulation 536/2014 (EU-CTR), replacing the EU Clinical Trial Directive (Directive…

Certara2022 年 9 月 26 日

Podcast

Certara – Improving Investment in Drug Development through Biosimulation

Jim Gallagher2022 年 9 月 23 日

On-Demand Webinar

Optimize drug development with public data and predictive models – model-based meta-analysis (MBMA)

Properly understanding the probability of successful drug development requires utilization of all available information. Critical…

Becca Bucci2022 年 9 月 23 日

Blog

3 Takeaways from the FDA Oligo Guidance You Need to Know

In June 2022, the FDA published their first oligonucleotide clinical pharmacology specific guidance . This…

Certara2022 年 9 月 23 日

On-Demand Webinar

Pinnacle 21 Data Exchange: Transforming External Vendor Data Management

The volume and complexity of clinical data are growing at a faster pace than the…

Jim Gallagher2022 年 9 月 19 日

Fact Sheet

利用生物模拟和监管科学加速儿科药物开发

Jim Gallagher2022 年 9 月 13 日

Article

Certara Hosts Seminar on Drug Discovery Challenges in Japan and How Modeling and Simulation Can Solve Them

“Quantitative decision-making with data rather than empirical thinking" - Certara's Modeling & Simulation technology contributes…

Certara2022 年 9 月 13 日

On-Demand Webinar

应对生物技术融资危机：如何实现下一个价值拐点

For the past two years, the biotech sector saw a surge of venture funding and…

Becca Bucci2022 年 8 月 30 日

Blog

3 Major Implications of New European Clinical Trial Regulations

Have you heard the buzz around the new European Union Clinical Trial Regulations (EU-CTR) for…

Certara2022 年 8 月 25 日

Blog

令人惊叹的 QSP 在药物开发中的应用：Part 2

Part 2 of this blog series dives further into the June 2022 podcast with R&D…

Certara2022 年 8 月 15 日

pre-update

EU-CTR Challenges Drug Developers Faced in the First 6 Months

Certara – Improving Investment in Drug Development through Biosimulation

Optimize drug development with public data and predictive models – model-based meta-analysis (MBMA)

3 Takeaways from the FDA Oligo Guidance You Need to Know

Pinnacle 21 Data Exchange: Transforming External Vendor Data Management

利用生物模拟和监管科学加速儿科药物开发

Certara Hosts Seminar on Drug Discovery Challenges in Japan and How Modeling and Simulation Can Solve Them

应对生物技术融资危机：如何实现下一个价值拐点

3 Major Implications of New European Clinical Trial Regulations

令人惊叹的 QSP 在药物开发中的应用：Part 2

订阅时事通讯

快捷链接

解决方案

联系我们